Clinical Trials Logo

Oral Mucositis clinical trials

View clinical trials related to Oral Mucositis.

Filter by:

NCT ID: NCT01163097 Completed - Oral Mucositis Clinical Trials

Study to Characterize the Effect of Heparin on Palifermin Activity

Start date: July 2010
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the effect of a continuous intravenous infusion of unfractionated heparin on the multiple-dose pharmacodynamics of palifermin in healthy adult subjects.

NCT ID: NCT01115049 Completed - Oral Mucositis Clinical Trials

Hexetidine and Chlorobutanol for Lesions Due to Prostheses

Start date: February 2010
Phase: Phase 4
Study type: Interventional

Objectives: The study aimed at assessing the efficacy of a new mouthwash in treating oral lesions due to removable prostheses. Methods: The present prospective randomized clinical trial was performed on 44 patients. The experimentation lasted for 4 weeks and 4 operators participated. The effects of the mouthwash were evaluated subjectively and objectively, with questionnaires, Visual Analogic Scales and clinical examinations. The results were statistically analyzed. The following variables were recorded: presence of mucosal lesions due to incongruous removable prostheses and lasting of pain after rinsing.

NCT ID: NCT01083875 Completed - Oral Mucositis Clinical Trials

Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region

Start date: February 2000
Phase: Phase 2
Study type: Interventional

The purpose of this study was to determine the effect of 0.5% amlexanox oral rinse compared to a vehicle control on mucositis-related ulceration and erythema (objective score)and on mucositis-related oral pain (subjective score). A secondary objective was to evaluate the safety of 0.5% amlexanox oral rinse by determining the frequency of treatment-emergent drug-related adverse events or clinical laboratory abnormalities.

NCT ID: NCT01036633 Completed - Oral Mucositis Clinical Trials

Oral Mucositis in Patients Undergoing Antineoplastic Chemotherapy

Mucositis
Start date: August 2009
Phase: N/A
Study type: Observational

The purpose of this study was to: 1. To investigate the feasibility of using infrared (IR) thermometer to grade the severity of oral mucositis in patients with multiple myeloma undergoing chemotherapy. 2. To obtain preliminary data on the most optimal method of scoring the severity of oral mucositis by comparing the results obtained using the IR thermometer to the World Health Organization (WHO) mucositis grading system and the patient self-assessment questionnaire. 3. To Investigate the correlation between the quantitative readings obtained from oral mucosa with the IR thermometer.

NCT ID: NCT01007617 Recruiting - Oral Mucositis Clinical Trials

Low-energy Laser Therapy for Prevention of Oral Mucositis in Children

Start date: June 2009
Phase: Phase 2/Phase 3
Study type: Interventional

Oral mucositis represents a major complication of cytotoxic chemotherapy among cancer in children. Low-power laser therapy (LPLT) has been used to reduce the incidence of oral mucositis in patients who are receiving high-dose chemotherapy. The aim of this study is to compare two preventives energies delivered of LPLT to oral mucosa in decreasing the severity of mucositis in children.

NCT ID: NCT00965172 Completed - Sarcoma Clinical Trials

Caphosol in Sarcoma Patients With Mucositis

Start date: April 2010
Phase: Phase 2
Study type: Interventional

The goal of this clinical research study is to find out if Caphosol® (calcium phosphate) mouthwash is more effective than a baking soda solution at preventing and treating mucositis, in patients with sarcoma who are to be treated with chemotherapy. The safety of this drug will also be studied. Researchers also want to learn about the way calcium phosphate may affect mucous membranes. The goal of this clinical research study is to see if Caphosol® (calcium phosphate) mouthwash is better than baking soda solution in patients with sarcoma who are to be treated with chemotherapy . Caphosol will also be studied to see if it lessens the incidence and severity of oral mucositis (painful sores in the mouth).

NCT ID: NCT00938080 Completed - Oral Mucositis Clinical Trials

Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and Neck

Start date: September 2009
Phase: Phase 1
Study type: Interventional

The purpose of this study is to assess the safety and tolerability of AG013 (genetically modified L. lactis bacteria engineered to secrete human Trefoil Factor 1), and to explore the ability of AG013 to attenuate the course and severity of oral mucositis (OM) in subjects receiving induction chemotherapy for the treatment of head and neck cancer.

NCT ID: NCT00901732 Recruiting - Oral Mucositis Clinical Trials

Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer

Start date: May 2009
Phase: Phase 1/Phase 2
Study type: Interventional

Patients who have been diagnosed with a head and/or neck cancer commonly develop oral mucositis (OM). The purpose of this study is to estimate the effect of Caphosol on OM and to evaluate if Caphosol had any effect on clinical outcomes which include quality of life, oral intake, swallowing function and pain.

NCT ID: NCT00845819 Completed - Oral Mucositis Clinical Trials

Study of Epidermal Growth Factor on Oral Mucositis Induced by Intensive Chemotherapy for Hematologic Malignancies

EGFOM
Start date: February 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine efficacy and toxicity of recombinant human epidermal growth factor (rhEGF) as a preventive drug of oral mucositis during intensive chemotherapy with stem cell transplantation in patients with hematologic malignancies.

NCT ID: NCT00804817 Completed - Malnutrition Clinical Trials

Somatic-psychosocial Care Concept for Oncologic Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)

Start date: December 2007
Phase: N/A
Study type: Interventional

This study will test the SCION (Self care improvement through oncology nursing)-HSCT program a multi-modular, somatic-psycho-social care intervention to improve self management in oncologic patients undergoing HSCT. The study will determine if the self management skills of the patients to enhance: - physical activity, - prevention of oral mucositis and - mal nutrition during the period of hospitalization. It is hypothesized that patients who receive the multi-modular somatic-psycho-social care intervention will have better health related quality of life (HRQoL).